Baby Blue Eyes (Nemophila menziesii): A Comprehensive Reference
1. Identity and Botanical Description
Baby blue eyes is the common name most widely applied to Nemophila menziesii Hook. & Arn., an annual herb native to western North America. The species is also historically listed under the synonym Nemophila insignis. The two names — Nemophila menziesii and Nemophila insignis — both refer to the same plant known for its soft blue flowers with white centers.
The genus Nemophila is found in the flowering plant family Hydrophyllaceae (now treated as a subfamily of Boraginaceae), and most species in the genus contain the phrase "baby blue eyes" in their common names; N. menziesii in particular holds the name "baby blue eyes." Related species include N. parviflora (smallflower baby blue eyes) and N. spatulata (Sierra baby blue eyes), while an exception to the naming pattern is N. maculata, whose common name is fivespot.
The genus Nemophila comprises approximately 13 species of annual herbaceous plants in the family Boraginaceae, native primarily to western North America from Canada to Mexico. Historically, Nemophila was initially classified within the family Hydrophyllaceae; molecular phylogenetic studies in the 2000s and 2010s revealed that Hydrophyllaceae was nested within the broader Boraginaceae, leading to the merger of the former family into the latter around 2013, with Nemophila placed in subfamily Hydrophylloideae to reflect these relationships.
The Latin genus name Nemophila means "woodland-loving," derived from the Latin word nemos (a glade or wooded pasture) and the Greek word philos (loving). The species epithet menziesii is attributed to Scottish naturalist and physician Archibald Menzies, who brought back many new varieties of plants from a fur-trading sea voyage around Cape Horn in 1786.
Morphology: Baby blue eyes is a low-growing annual herbaceous plant characterized by fleshy stems reaching 8–12 inches (20–30 cm) in height, small gray-green pinnately lobed leaves, and saucer-shaped bright blue flowers measuring about 1.5 inches (3.8 cm) across with white or light blue centers and darker spots. The flower is blue with a white center or all white, usually with blue veins and black dots near the center. Lower leaves are stalked, lobed, and oppositely arranged, 10–50 millimetres (0.4–2.0 in), with five to thirteen lobes, each entire or with one to three teeth.
Recognized varieties:
- Nemophila menziesii var. menziesii has bright blue flowers with white centers that are generally dotted with black; it is found virtually throughout California, in meadows, grasslands, chaparral, woodlands, slopes, and desert washes, but does not occur above 5,200 feet (1,600 meters).
- Nemophila menziesii var. atomaria has white flowers with black dots, often with a faint blue tint or blue veins in the corolla; it is found on coastal bluffs or grassy slopes in Oregon, Northwestern California, the Central Coast of California, and the San Francisco Bay Area.
- Nemophila menziesii var. integrifolia has blue flowers with black dots at the center and deep blue veins; it is found in grasslands, canyons, woodlands, and slopes in the Central Coast, southern Coast Ranges, southwestern California, east of the Sierra Nevada range, and into the Mojave Desert and Baja California.
Geographic range and habitat: The species is native to Oregon, California, northern Baja California in Mexico, and southern Nevada, and blooms from spring to summer, producing seeds that allow it to self-sow readily in suitable conditions. It grows virtually throughout California at elevations from sea level up to almost 6,500 feet (2,000 m). It grows in many types of habitats, including chaparral, valley grasslands, and montane locales.
2. Common Forms and Preparations as a Supplement
Baby blue eyes is not a conventional herbal supplement or dietary ingredient in the pharmacological or nutritional sense. It is almost exclusively encountered commercially as a flower essence — a highly diluted preparation intended to address emotional and psychological states rather than to deliver phytochemical compounds. Flower essences contain no physical plant material, have no scent, and are typically preserved in alcohol (usually brandy or vodka); unlike herbal tinctures or essential oils, they are not valued for their chemical compounds, but rather proponents describe them as a form of vibrational energy medicine that works on emotional states rather than physical symptoms.
Baby blue eyes flower essence is produced by the Flower Essence Society (FES), based in Nevada City, California, as part of their "FES Quintessentials" line, and by several other producers worldwide. FES essences are available individually in 1/4 oz (7.5 ml) or 1 oz (30 ml) bottles, sold at stock strength; the full collection comprises 103 FES Quintessentials essences.
The sun method of preparation: The sun method, devised for more delicate flowers, involves floating the flower heads in pure water for three hours, in direct sunlight. The energised water is then filtered and an equal quantity of brandy is added to it as a preservative, creating the mother tincture; this mother tincture is then further diluted at a ratio of two drops to every 30 ml to make the stock bottles sold in shops.
Bach flower remedies (BFRs) are solutions of brandy and water — the water containing extreme dilutions of flower material. The dilution process results in the statistical likelihood that little more than a single molecule of plant material may remain; it is claimed that the remedies contain an "energetic" or "vibrational" nature of the flower that can be transmitted to the user.
The three hierarchical dilution levels used commercially are:
- Mother essence: The original preparation is 50% water from the crafting process and 50% brandy.
- Stock bottle: To make a stock bottle, 7 drops from the mother are added to a neutral solution of 75% water and 25% brandy; this is the level at which commercial single essences are typically sold.
- Dosage bottle: The dosage bottle is a blend of flower essences from the stock level dilution; a practitioner-made formula typically blends 5–7 stock-level essences in a solution of 80% water and 20% brandy.
Alcohol content at the dosage level is extremely low. Dilution methods ensure that any alcohol ingested is chemically and physiologically insignificant — about one part in 600 when diluted in a one-ounce (30 ml) dosage bottle, or about one part in 4,800 in an eight-ounce glass of water.
3. Traditional and Historical Use
3.1 Indigenous and Ethnobotanical History
No documented tradition of medicinal use of Nemophila menziesii in indigenous North American botanical medicine appears in the available scholarly literature. The only confirmed historical use of the plant itself among indigenous peoples is agricultural: the plant is an annual herb native to western North America, and historically it was eaten by cows kept by the Kawaiisu. The Kawaiisu are a Southern Paiute-related people of the Tehachapi region of California. This reflects the plant's role as forage rather than as a human food or medicine in the documented ethnobotanical record.
3.2 Flower Essence Tradition: Origins
The 38 original Bach flower remedies were all discovered in the 1920s and 1930s by Dr. Edward Bach, a well-known bacteriologist, physician, and pathologist; each remedy was associated with a basic human emotion. Baby blue eyes (Nemophila menziesii), however, is not one of the original 38 Bach remedies. It belongs to a later, expanded system.
The FES Quintessentials were developed to meet the needs of modern consciousness, adding to those identified by Dr. Edward Bach in the 1930s; corroborated by over four decades of case studies and practitioner reports from around the world, the FES Quintessentials have developed a professional reputation; these remedies are stated by their makers to address the emotional and psychological aspects of mind-body wellness.
Bach derived his solutions intuitively and based on his perceived psychic connections to the plants, rather than using research-based scientific methods; if Bach felt a negative emotion, he would hold his hand over different plants, and if one alleviated the emotion, he would ascribe the power to heal that emotional problem to that plant. The FES approach to expanding the flower essence pharmacopoeia followed similar principles: practitioners and researchers observe and intuit correspondences between the morphological and ecological characteristics of plants and human psychological states, then document findings through case studies.
3.3 Stated Traditional Indications in Flower Essence Practice
Within the flower essence tradition, the uses attributed to baby blue eyes are purely psychological and spiritual. The primary indication system used by FES describes the essence in terms of "positive qualities" and "patterns of imbalance":
- FES lists the positive qualities of baby blue eyes (Nemophila menziesii) as childlike innocence and trust, feeling supported and loved especially by male figures, and faith in the providence of spiritual beings; the patterns of imbalance addressed include defensiveness, insecurity, mistrust of others, estrangement from higher spiritual authority, and lack of support from the father or other masculine influences in childhood.
The preparation was developed in the context of the California flower essence tradition, using flowers gathered wild from the native range of the plant. The commercial product from Flower Essence Services lists its ingredients as brandy, water, and infusion of baby blue eyes flowers gathered wild.
4. Key Constituents and Active Compounds
Research on the phytochemistry of Nemophila menziesii has focused almost entirely on pigment chemistry — specifically the compounds responsible for the plant's distinctive blue flower color. This research is conducted in the context of plant biochemistry and flower color engineering, not in the context of human therapeutic use. Because flower essence preparations contain extreme dilutions rendering measurable plant material statistically absent, the following phytochemical information describes the source plant rather than the finished supplement product.
4.1 Metalloanthocyanins
The most scientifically well-characterized compound from Nemophila menziesii is a novel metalloanthocyanin called nemophilin. A novel metalloanthocyanin, nemophilin, was found in the blue petals of Nemophila menziesii. The blue flower color of Nemophila menziesii is derived from this metalloanthocyanin, nemophilin, which comprises petunidin-3-O-[6-O-(trans-p-coumaroyl)-β-glucoside]-5-O-[6-O-(malonyl)-β-glucoside], apigenin-7-O-β-glucoside-4′-O-(6-O-malonyl)-β-glucoside, and Mg²⁺ and Fe³⁺ ions.
Reconstruction experiments using the anthocyanin and flavone components with various combinations of metal ions were conducted; NM and MP with magnesium ions yielded purplish-blue-colored metalloanthocyanin (Mg–Mg nemophilin), and NM and MP with both magnesium and iron ions generated a blue metalloanthocyanin (Fe–Mg nemophilin).
Anthocyanin is a flavonoid pigment found in plants that exhibits colors ranging from red to purple and blue; the color of a solution of anthocyanins changes depending on pH — red in acidic conditions, purple in neutral conditions, and blue in alkaline conditions; however, the pH of the vacuole where anthocyanins are dissolved is generally weakly acidic, so several special mechanisms exist for blue coloration in petal vacuoles, and the formation of metal complexes of anthocyanins is very important for true blue color development.
4.2 Flavonoids
In addition to the anthocyanin component of nemophilin, several flavonoid glycosides have been isolated from the flowers. Two anthocyanins were isolated from the blue flowers and identified as petunidin derivatives, with one confirmed as a new anthocyanin in plants; two flavonol glycosides and two flavone glycosides were also isolated and identified as kaempferol 3-(6-rhamnosyl)-glucoside-7-glucoside, apigenin 7,4′-di-glucoside, kaempferol 3-(2,6-di-rhamnosyl)-glucoside, and apigenin 7-glucoside-4′-(6-malonyl)-glucoside as the major flavonoids.
The blue color of the Nemophila menziesii flower is derived from metalloanthocyanin, which consists of anthocyanin, flavone, and metal ions; the flavone 7-O-β-glucoside-4′-O-β-glucoside in the plant is sequentially biosynthesized from flavones by two flavone glucosyltransferases (NmF4′GT and NmF4′G7GT).
4.3 Biosynthetic Pathway Characterization
The flavonoid biosynthetic pathway of nemophilin had not been characterized until relatively recently; RNA-Seq analysis of the petals yielded 61,491 contigs, which were searched using BLAST against petunia or torenia flavonoid biosynthetic proteins, identifying 11 putative full-length protein sequences belonging to the flavonoid biosynthetic pathway.
Spatio-temporal transcriptome analysis indicated that genes involved in the early part of the pathway are strongly expressed during early-petal development, and that those in the late part are expressed at late-flower opening stages, but they are rarely expressed in leaves.
It must be emphasized that none of this phytochemical research has been conducted in the context of human health applications. The research is directed entirely toward understanding and engineering blue flower coloration in ornamental plants. No pharmacological, toxicological, or clinical studies on extracts of Nemophila menziesii directed at human health outcomes have been identified in the available peer-reviewed literature.
5. Proposed Mechanisms of Action
Within the flower essence tradition, there is no biochemically grounded mechanism of action. Flower essence therapy uses highly diluted botanical extracts claimed to modulate emotional states; while millions of users report effects, clinical science categorizes these preparations as biologically inert.
The theoretical framework proposed by practitioners is vibrational or energetic in nature. According to Dr. Edward Bach, the sun transfers the energy of the flowers into the medium of the water, which becomes "energetically impregnated." The dilution process results in the statistical likelihood that little more than a single molecule may remain; it is claimed that the remedies contain the "energetic" or "vibrational" nature of the flower and that this can be transmitted to the user. This mechanism has no established basis in chemistry, biology, or physics.
For the intact plant, the flavonoid and anthocyanin compounds identified in Nemophila menziesii — particularly petunidin and apigenin glycosides — belong to classes of compounds studied broadly in pharmacology. Petunidin (a delphinidin-type anthocyanin) and apigenin glycosides are the subject of research in other plant species for antioxidant, anti-inflammatory, and other properties. However, no studies have examined these activities in Nemophila menziesii extracts specifically, and such research cannot be extrapolated to the finished diluted flower essence product.
6. Scientific Evidence by Area of Use
6.1 Baby Blue Eyes Specifically
No peer-reviewed human clinical trials, animal studies, or mechanistic studies examining baby blue eyes (Nemophila menziesii) flower essence or any extract of Nemophila menziesii for any health outcome have been identified in the available scientific literature. The botanical chemistry studies described above (on nemophilin, flavone glucosyltransferases, and metalloanthocyanins) are not conducted in the context of human health. The flower essence preparation itself contains no detectable plant material after dilution, making phytochemical effects mechanistically implausible.
6.2 Flower Essence Therapy: General Evidence Base (Applicable to Baby Blue Eyes as a Category)
Because baby blue eyes flower essence belongs to the broader category of flower remedy/flower essence preparations, the clinical trial evidence on flower essence therapy as a class is the most relevant scientific context in which to evaluate claims made for it.
Systematic reviews:
Bach flower remedies continue to be popular and their proponents make a range of medicinal claims for them; a 2010 systematic review (Ernst E., Swiss Medical Weekly) critically evaluated the evidence, searching five electronic databases without restrictions on time or language and including all randomised clinical trials of flower remedies; seven such studies were located, all but one placebo-controlled; all placebo-controlled trials failed to demonstrate efficacy; it is concluded that the most reliable clinical trials do not show any differences between flower remedies and placebos.
Future trials were recommended to employ methods that minimize bias and confounding such as randomization and blinding, to be conducted with an adequate sample size to detect effects with statistical significance, to minimize loss-to-follow-up, and to analyze patient-relevant end-point parameters.
Individual controlled studies on flower essences:
Studies that used flower essence therapy to reduce stress levels, despite having obtained some beneficial results, showed methodological weaknesses for a clinical trial, mainly related to sample size and blinding.
Results from one study showed no effect of using a pre-determined mix of five remedies to reduce food cravings and BMI; in a parallel arm, there were reductions in both BMI and food cravings in the group taking remedies, however, the study was not blind and authors correctly stated that the therapeutic ritual may have resulted in the observed improvements.
Summary of evidence strength: The overall clinical evidence base for flower essence therapy — including any product containing baby blue eyes — is weak. All well-designed (randomized, placebo-controlled, blinded) trials have failed to find effects beyond placebo. Positive findings in uncontrolled or non-blinded studies are confounded by ritual, expectation, and placebo effects. No peer-reviewed evidence supports any specific health claim for baby blue eyes flower essence beyond what could be attributed to placebo response.
6.3 ADHD in Children (Flower Essences Generally)
A prospective double-blind controlled study examined Bach flower remedies used for attention deficit hyperactivity disorder in children (Pintov et al., European Journal of Paediatric Neurology, 2005, Vol. 9(6), pp. 395–398). This study did not involve baby blue eyes specifically and the NCCIH-referenced review notes its inclusion within the broader systematic literature on flower remedies.
7. Body Systems and Health Areas Associated with Baby Blue Eyes Flower Essence
The associations claimed for baby blue eyes flower essence in the flower essence tradition are exclusively psychological and relational, not physiological. Based on published practitioner materials, the following domains are cited:
- Emotional/psychological health: The primary indication is recovery of the innocence and trust of the inner child, feeling at ease in the world, feeling helped and loved; the stated pattern of imbalance addressed includes defensiveness, insecurity, and distrust of others, as well as lack of support from the father during childhood.
- Interpersonal and relational functioning: Within flower essence practice, baby blue eyes is associated with healing patterns of mistrust, difficulty connecting with others, and emotional isolation rooted in early-life experiences — particularly regarding paternal relationships.
- Spiritual well-being: FES describes this category of remedies as addressing the emotional and psychological aspects of mind-body wellness.
None of these associations have been evaluated in peer-reviewed clinical research specific to baby blue eyes. The categorization of flower essences as targeting emotional states rather than organic disease is consistent with their general characterization in the literature. Flower essences are primarily used to support the emotional, mental, and spiritual body.
8. Dosage Forms and Reported Dosages
The following dosages are reported in commercial product labeling and practitioner guidance documents, not in peer-reviewed clinical trials (since no trials exist for baby blue eyes specifically):
- Stock bottle dosage (FES/commercial): The Flower Essence Society suggests four drops, four times daily for baby blue eyes (Nemophila menziesii) flower essence.
- Dilution method (commercial product): Add 2 drops to water, and take 4 times daily.
- Dosage bottle preparation (FES official guidance): Fill a 30 ml dropper bottle with water (three-quarters volume) and brandy (one-quarter volume as preservative); add 2 to 4 drops of the chosen floral essence from the stock bottle; shake lightly before taking; take four drops under the tongue four times a day.
- Alternative for alcohol-sensitive individuals: Use two to four drops of stock essence in a large glass of water or juice, stir, and sip slowly. An alternative is to prepare the essences in a dosage bottle using apple cider vinegar as preservative instead of brandy.
- Duration: A 30 ml / 1 oz dosage bottle taken at four drops four times daily will last approximately three to four weeks.
These dosing instructions reflect flower essence practice tradition, not evidence-based pharmacological protocols. No dose-response studies, pharmacokinetic data, or efficacy-optimized dosing studies exist for baby blue eyes flower essence.
9. Safety Considerations and Interactions
9.1 Overall Safety Profile
Bach flower remedies are considered possibly safe when used in moderation; since most contain little or no active ingredient, these products are not expected to cause harm, but they are preserved in brandy and therefore contain alcohol. This applies equally to FES essences such as baby blue eyes, which follow the same preparation principles.
Since flower essences are diluted solutions, they are generally considered safe; but like all remedies, essences can still cause unwanted side effects.
9.2 Alcohol Content
The brandy preservative is the primary safety consideration. At the dosage level, the alcohol content is chemically and physiologically insignificant — about one part in 600 when diluted in a one-ounce (30 ml) dosage bottle, or about one part in 4,800 in an eight-ounce glass of water.
However, for certain populations the alcohol base warrants consideration:
- Pregnancy and breastfeeding: Bach flower remedies are considered likely unsafe when taken by mouth during pregnancy or breastfeeding because they contain alcohol; alcohol can cause birth defects and other harm to infants. While most practitioners say flower essences are safe during pregnancy or breastfeeding, use of an alcohol-free version is recommended if concerned.
- Alcohol sensitivity or recovery: Many recovering alcoholics and other alcohol-sensitive persons have used flower essences; although flower remedies are preserved with brandy at the stock level, success has been reported in diluting essences to the dosage level without the use of alcohol, since dilution methods ensure the alcohol content is chemically and physiologically insignificant.
9.3 Absence of Plant Material and Toxicity Risk
The water in a flower essence is filtered and preserved with brandy; the finished essence contains no part of the flower. Consequently, any potential toxicity from plant compounds in Nemophila menziesii — which in any case is not documented in the literature — would not be relevant to the finished product. No toxicological studies on Nemophila menziesii preparations in humans or animals have been identified in peer-reviewed literature.
9.4 Regulatory Status
Flower essences are sold as dietary supplements in the United States and are not approved as drugs by the FDA. The hypothesis that flower remedies are associated with effects beyond a placebo response is not supported by data from rigorous clinical trials. No government health authority — including the NIH Office of Dietary Supplements, NCCIH, EMA, or EFSA — has issued a positive monograph, approved health claim, or endorsement for baby blue eyes or Nemophila menziesii preparations for any health indication.
9.5 Drug Interactions
No documented pharmacokinetic or pharmacodynamic drug interactions for baby blue eyes flower essence or Nemophila menziesii preparations have been identified in the peer-reviewed literature. Given the absence of measurable plant compounds at the dilution levels used, pharmacological interactions are not mechanistically expected. The low alcohol content at dosage levels is not expected to interact with medications in the manner that higher-alcohol preparations might.
10. Nomenclature Note: Other Plants Called "Baby Blue Eyes"
The common name "baby blue eyes" is occasionally applied to other plants, most notably Omphalodes linifolia (Venus's navelwort), a member of the Boraginaceae from the Mediterranean region. Omphalodes, also known as blue-eyed Mary, is a low-growing ground cover; it is also known as creeping forget-me-not and navelwort. It belongs to the genus Boraginaceae and is native to woodlands, grasslands, and rocky areas in Europe and Asia. This plant is entirely distinct from Nemophila menziesii and is not known to be used as a supplement or flower essence under the "baby blue eyes" name. The vast majority of commercial "baby blue eyes" supplement and flower essence products refer exclusively to Nemophila menziesii.
References
Volver